|Day Low/High||219.26 / 221.45|
|52 Wk Low/High||159.42 / 236.86|
This COVID-19 vaccine is the potential savior of more than just the market.
HON's outstanding quarter shows they're hitting on all cylinders while increasing margin in the process.
Plus, what could be next out of the central banks and Congress and how it could affect Treasuries.
Good morning one and all, I'm Chris Versace, filling in for Doug Kass on the Daily Diary, and if you were expecting a sleepy summer Friday, not only do we have a bunch of quarterly earnings reports from American Express , Honeywell , Kimberly-Clark ...
Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.
Here's where aggressive traders could go long HON at current levels.
The first step is to recognize what is going on as major indices go one way and speculative stocks go another.
Let's look at the companies that can go up, and the ones that can't.
This is that 72-hour period when the most important names report. Here's what you need to know to get through it.
Getting dizzy looking down from here? Then look up, because we may just be getting started on this market.
My target price has been $260 for HON for some time. I see no reason to change that now.
The president's plans to raise taxes aren't a surprise, but hiking the capital gains rate significantly isn't such a hot idea.
Don't fear the taxman, view this one as an opportunity, not a penalty.
Amazingly, one group isn't just left behind, it just keeps losing money, while the other group is shrugging off this day with aplomb.
Fundamentals and valuations are secondary to shifting money into certain sectors.
BA may be a buy on this weakness. The charts show some pressure in the short-term, but longer-term, the skies are clearing.
It may seem ridiculous, but you can distill the market down to these two names because they stand for palpable themes.
The near-term direction of the technology and manufacturing giant's shares isn't clear from its technical patterns.
Tuesday was a quirky sort of day that came ahead of the FOMC policy decision set for this (Wednesday) afternoon.
One of the most continual themes in this market is that anything that was liked last year is hated this year.
In which we discuss the seven heavenly ways to make money and the seven sins to watch for.
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
There is a bit of mixed feeling to these earnings results.
One of the scary stories deals with what could happen if there was coordinated gaming of the U.S. dollar.
My trading strategy? Figure out who is the favorite and calculate the 'line.' Here's how that works out today.
In four months, NNDM will have raised $1 billion in cash.
Enroll the private sector that has the capability of vaccinating en masse and save the kingdom.